Related Experiment Video
Updated: Apr 24, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
ProQSAR: A modular and reproducible framework for small-data QSAR modeling with fit-and-use models
Tuyet-Minh Phan1,2,3, Tieu-Long Phan4,5, Phuoc-Chung Van-Nguyen1
1School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, 41 Dinh Tien Hoang, Saigon Ward, Ho Chi Minh City, 700000, Vietnam.
Background:
Quantitative structure-activity relationship (QSAR) models are central to computer-aided drug discovery and predictive toxicology, but practical adoption is often impeded by ad-hoc tooling, inconsistent validation protocols, and poor reproducibility.
Objective:
We introduce ProQSAR, a modular, reproducible workbench that formalizes end-to-end QSAR development while permitting independent use of each component.
Methods:
ProQSAR composes interchangeable modules for standardization, feature generation, splitting (including scaffold- and cluster-aware splits), preprocessing, outlier handling, scaling, feature selection, model training and tuning, statistical comparison, conformal calibration, and applicability-domain assessment. The pipeline can run end-to-end to produce versioned artifact bundles (serialized models) and analyst-oriented reports suitable for deployment and audit.
Results:
On representative MoleculeNet benchmarks evaluated under Bemis-Murcko scaffold split, ProQSAR attains state-of-the-art descriptor-based performance: the lowest mean RMSE across the regression suite (ESOL, FreeSolv, Lipophilicity; mean RMSE ), including a substantial improvement on FreeSolv (RMSE vs. for a leading graph method). On quantum mechanical benchmarks, ProQSAR demonstrated superior performance on the single-task dataset QM7 and maintained competitive results on the multi-task QM8 dataset. For classification, ProQSAR achieves the top ROC-AUC on ClinTox (91.4%) while remaining competitive across other benchmark (overall classification average ). Crucially, all predictions are accompanied by cross-conformal prediction and explicit applicability-domain flags that identify out-of-distribution entries, enabling calibrated and decision support.
Availability:
ProQSAR is released on PyPI, Conda, and Docker Hub; all releases embed full provenance (parameters, package versions, checksums) to ensure reproducibility.
Scientific Contribution:
ProQSAR (i) enforces best-practice, group-aware validation together with formal statistical comparisons across models, (ii) integrates calibrated uncertainty quantification (cross-conformal prediction) and applicability-domain diagnostics for interpretable, risk-aware predictions, and (iii) exposes both a composable developer API and a one-click pipeline that generates deployment-ready artifacts and human-readable reports, demonstrated on representative benchmarks.
More Related Videos
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
10:27Contrast-Matching Detergent in Small-Angle Neutron Scattering Experiments for Membrane Protein Structural Analysis and Ab Initio Modeling
Published on: October 21, 2018
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Mechanistic Models: Compartment Models in Individual and Population Analysis